Description
Retatrutide is a synthetic peptide research compound acting as a triple agonist at the GIP, GLP-1, and glucagon receptors. Researchers study it to examine three metabolic pathways engaged together.
In cultured cells and laboratory animals, work has focused on glucose regulation, energy output, lipid processing, and integrated three-receptor signaling. Its multi-target profile suits comparative metabolic research.
Intended use: In vitro and preclinical in vivo laboratory research only. Not approved for human or veterinary use.
Reviews
There are no reviews yet.